Previous close | 4.1400 |
Open | 4.1800 |
Bid | 4.2800 x 3200 |
Ask | 4.5000 x 21500 |
Day's range | 4.1500 - 4.3000 |
52-week range | 3.1200 - 11.7000 |
Volume | |
Avg. volume | 1,720,859 |
Market cap | 627.82M |
Beta (5Y monthly) | 1.62 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.2130 |
Earnings date | 03 Aug 2022 - 08 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 14.49 |
BRISBANE, Calif., June 01, 2022--SANGAMO THERAPEUTICS ANNOUNCES PARTICIPATION AT UPCOMING INVESTOR CONFERENCES
Sangamo (SGMO) delivered earnings and revenue surprises of 6.25% and 1.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
BRISBANE, Calif., May 05, 2022--SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FIRST QUARTER 2022 FINANCIAL RESULTS